TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP- and redox-independent chaperone.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
11 2023
Historique:
received: 11 08 2023
revised: 17 09 2023
accepted: 18 09 2023
medline: 30 10 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

TXNL1 (also named TRP32, for thioredoxin related protein of 32 kDa) is a cytosolic thioredoxin-fold protein expressed in all cell types and conserved from yeast to mammals, but with yet poorly known function. Here, we expressed and purified human TXNL1 together with several Cys-to-Ser variants, characterizing their enzymatic properties. TXNL1 could reduce disulfides in insulin, cystine and glutathione disulfide (GSSG) in reactions coupled to thioredoxin reductase (TXNRD1, TrxR1) using NADPH, similarly to thioredoxin (TXN, Trx1), but with lower catalytic efficacy due to at least one order of magnitude higher K

Identifiants

pubmed: 37804695
pii: S2213-2317(23)00298-7
doi: 10.1016/j.redox.2023.102897
pmc: PMC10570131
pii:
doi:

Substances chimiques

NADP 53-59-8
Cystine 48TCX9A1VT
Thioredoxins 52500-60-4
Thioredoxin-Disulfide Reductase EC 1.8.1.9
Insulins 0
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102897

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Attila Andor (A)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Mahendravarman Mohanraj (M)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Zsuzsanna Anna Pató (ZA)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Katalin Úri (K)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Beáta Biri-Kovács (B)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Qing Cheng (Q)

Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Elias S J Arnér (ESJ)

Department of Selenoprotein Research and the National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary; Division of Biochemistry, Department of Medical Biochemistry, Karolinska Institutet, SE-171 77, Stockholm, Sweden. Electronic address: elias.arner@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH